Senores Pharmaceuticals Limited — Board Meeting, 02-06-2025: Outcome of Board Meeting

Senores Pharmaceuticals has announced a board meeting on which it appointed Sharp & Tannan Associates as internal auditor for FY 2025-26. The Mumbai-based firm brings over 60 years of experience and will enhance audit efficiency with a focus on risk-based auditing, process optimization, and compliance. Senores aims to strengthen internal controls by leveraging advanced technologies like robotic process automation (RPA). No other financial or strategic updates were shared.